Enantioselective synthesis of α-quaternary Mannich adducts by palladium-catalyzed allylic alkylation

US11377396B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11377396-B2
Application numberUS-201916579382-A
CountryUS
Kind codeB2
Filing dateSep 23, 2019
Priority dateDec 18, 2014
Publication dateJul 5, 2022
Grant dateJul 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides enantioenriched Mannich adducts with quaternary stereogenic centers and novel methods of preparing the compounds. Methods include the method for the preparation of a compound of formula (I):comprising treating a compound of formula (II):with a transition metal catalyst under alkylation conditions.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising treating a compound of formula (IIa): with a transition metal catalyst under alkylation conditions, thereby preparing a compound of formula (Ia): wherein, as valence and stability permit, A, B, C, and D each independently represent, as valence permits, NR′, CR″R′″, C(O), O, S, CR″, or N; provided that no two adjacent occurrences of A, B, C, and D are NR′, O, S, or N; R′ represents hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), —S(O) 2 (alkyl),— S(O) 2 (haloalkyl), —OR 14 , —SR 14 , or —NR 14 R 15 ; R″ and R′″ each independently represent hydrogen, hydroxyl, halogen, nitro, alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, cyano, carboxyl, sulfate, amino, alkoxy, aryloxy, alkylamino, alkylthio, hydroxyalkyl, alkoxyalkyl, aminoalkyl, thioalkyl, ether, thioether, ester, amide, thioester, carbonate, carbamate, urea, sulfonate, sulfone, sulfoxide, sulfonamide, acyl, acyloxy, or acylamino; or any two occurrences of R′, R″, and R′″ on adjacent A, B, C, or D groups, taken together with the intervening atoms, form an optionally substituted aryl, heteroaryl, cycloalkyl, cycloalkenyl, heterocycloalkyl, or heterocycloalkenyl group; each occurrence of independently represents a double bond or a single bond as permitted by valence; m and n are integers each independently selected from 0, 1, and 2, wherein the sum of m and n is 1, 2, 3, or 4; R 1a and R 1b each independently represent hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), —S(O) 2 (alkyl), —S(O) 2 (haloalkyl), —OR 14 , —SR 14 , or —NR 14 R 15 ; R 2 and R 3 each independently represent hydrogen or substituted or unsubstituted alkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, alkylamino, hydroxyalkyl, alkoxyalkyl, aminoalkyl, or thioalkyl; R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 are each independently selected for each occurrence from hydrogen, hydroxyl, halogen, nitro, alkyl, alkenyl, alkynyl, cyano, carboxyl, sulfate, amino, alkoxy, alkylamino, alkylthio, hydroxyalkyl, alkoxyalkyl, aminoalkyl, thioalkyl, ether, thioether, ester, amide, thioester, carbonate, carbamate, urea, sulfonate, sulfone, sulfoxide, sulfonamide, acyl, acyloxy, acylamino, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, aralkyl, arylalkoxy, heteroaralkyl, (cycloalkyl)alkyl, and (heterocycloalkyl)alkyl; and R 14 and R 15 are independently selected for each occurrence from hydrogen or substituted or unsubstituted alkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, and alkynyl, wherein the compound represented by formula (Ia) has about 70% ee or greater. 2. The method of claim 1 , wherein the transition metal catalyst comprises a transition metal selected from palladium, nickel, and platinum. 3. The method of claim 1 , wherein the transition metal catalyst further comprises a chiral ligand. 4. The method of claim 1 , wherein the compound represented by formula (Ia) has about 80% ee or greater. 5. The method of claim 1 , wherein the compound represented by formula (Ia) has about 85% ee or greater. 6. The method of claim 1 , wherein the compound represented by formula (Ia) has about 90% ee or greater. 7. The method of claim 1 , wherein in the compound of Formula (Ia), A is NR′, B and C are each CR″R′″, and D is O, or A is O, B and C are each CR″R′″, and D is NR′; m and n are each 1. 8. The method of claim 1 , wherein in the compound of Formula (Ia), one of A, B, C, and D is NR′ and the remaining of A, B, C, and D are each CR″R′″; m and n are each 1. 9. The method of claim 1 , wherein further comprising converting the compound of Formula (Ia) to an isonitramine or sibirinine. 10. The method of claim 9 , wherein the method comprises a carbonyl reduction reaction. 11. The method of claim 9 , wherein the method comprises a hydroboration reaction. 12. A method comprising treating a compound of formula (IIa): with a transition metal catalyst under alkylation conditions, thereby preparing a compound of formula (Ia): wherein, as valence and stability permit, A, B, C, and D each independently represent, as valence permits, NR′, CR″R′″, C(O), O, S, CR″, or N; provided that no two adjacent occurrences of A, B, C, and D are NR′, O, S, or N; R′ represents hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), —S(O) 2 (alkyl), — S(O) 2 (haloalkyl), —OR 14 , —SR 14 , or —NR 14 R 15 ; R″ and R′″ each independently represent hydrogen, hydroxyl, halogen, nitro, alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, cyano, carboxyl, sulfate, amino, alkoxy, aryloxy, alkylamino, alkylthio, hydroxyalkyl, alkoxyalkyl, aminoalkyl, thioalkyl, ether, thioether, ester, amide, thioester, carbonate, carbamate, urea, sulfonate, sulfone, sulfoxide, sulfonamide, acyl, acyloxy, or acylamino; or any two occurrences of R′, R″, and R′″ on adjacent A, B, C, or D groups, taken together with the intervening atoms, form an optionally substituted aryl, heteroaryl, cycloalkyl, cycloalkenyl, heterocycloalkyl, or heterocycloalkenyl group; each occurrence of independently represents a double bond or a single bond as permitted by valence; m and n are integers each independently selected from 0, 1, and 2, wherein the sum of m and n is 1, 2, 3, or 4; R 1a and R 1b each independently represent hydrogen or optionally substituted alkyl, cycloalkyl, (cycloalkyl)alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, alkenyl, alkynyl, —C(O)alkyl, —C(O)aryl, —C(O)aralkyl, —C(O)heteroaryl, —C(O)heteroaralkyl, —C(O)O(alkyl), —C(O)O(aryl), —C(O)O(aralkyl), —C(O)O(heteroaryl), —C(O)O(heteroaralkyl), —S(O) 2 (aryl), — S(O) 2 (alkyl), —S(O) 2 (haloalkyl), —OR 14 , —SR 14 , or —NR 14 R 15 ; R 2 and R 3 each independently represent hydrogen or substituted or unsubstituted alkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, (cycloalkyl)alkyl, cycloalkyl, (heterocycloalkyl)alkyl, heterocycloalkyl, alkenyl, alkynyl, alkylamino, hydroxyalkyl, alkoxyalkyl, aminoalkyl, or thioalkyl; R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , and R 11 are eac

Assignees

Inventors

Classifications

  • Oxygen atoms · CPC title

  • the ring being saturated · CPC title

  • with oxygen atoms directly attached to ring carbon atoms · CPC title

  • attached in position 2 or 6 · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11377396B2 cover?
This invention provides enantioenriched Mannich adducts with quaternary stereogenic centers and novel methods of preparing the compounds. Methods include the method for the preparation of a compound of formula (I):comprising treating a compound of formula (II):with a transition metal catalyst under alkylation conditions.
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification C07B53/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).